MedTrace Logo

Evaluation of PatientToc in Community Pharmacies

NCT05235620 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1175

Last updated 2024-04-05

No results posted yet for this study

Summary

The purpose of this study is to evaluate the initial "spread and scale" of PatientToc™, a patient-reported outcomes (PROs) collection software, to community pharmacies for the collection and use of PROs data pertaining to medication adherence. The investigators are doing this by engaging PatientToc™ and pharmacy partners in two plan-do-study-act (PDSA) cycles to implement and refine PatientToc™ and an implementation toolkit (i.e., supports/resource tools) within a small number of community pharmacies. Investigators will then scale implementation to more community pharmacies in a rigorous theory-driven evaluation of PatientToc™ implementation using interviews, self-reported data from the pharmacy, observations, and administrative data. Collectively, the findings will inform long-term collection and use of PROs data pertaining to medication use.

Conditions

  • Medication Adherence

Interventions

OTHER

PatientToc use in pharmacies

PatientToc has been adapted for use in pharmacies. Patients using specific medications will be prompted to complete questionnaires about their self-reported adherence.

Sponsors & Collaborators

  • University of Wisconsin, Madison

    collaborator OTHER

  • University of Minnesota

    collaborator OTHER

  • University of Arkansas

    collaborator OTHER

  • L.A. Net Community Health Resource Network

    collaborator OTHER

  • Agency for Healthcare Research and Quality (AHRQ)

    collaborator FED

  • Indiana Clinical and Translational Sciences Institute

    collaborator OTHER

  • Purdue University

    lead OTHER

Principal Investigators

  • Margie E Snyder, PharmD, MPH · Purdue University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2024-03-28
Completion
2024-03-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05235620 on ClinicalTrials.gov